Golden Green, Inc. Intellia Therapeutics, Inc. Transaction History

Golden Green, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$58.27 - $118.99 $175,625 - $358,635	-3,014 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$100.76 - $138.36 $116,881 - $160,497	1,160 Added 62.57%	3,014 $356,000
Q3 2021 Oct 08, 2021	SELL	$132.37 - $176.78 $7,545 - $10,076	-57 Reduced 2.98%	1,854 $249,000
Q2 2021 Jul 14, 2021	BUY	$60.88 - $161.91 $116,341 - $309,410	1,911 New	1,911 $309,000
Q1 2021 Apr 13, 2021	SELL	$46.59 - $83.68 $209,049 - $375,472	-4,487 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$18.83 - $63.53 $84,490 - $285,059	4,487 New	4,487 $244,000

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.06B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Golden Green, Inc., based on Form 13F filings with the SEC.

Stay updated on Golden Green, Inc. with notifications on news.